ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 97 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $716,436,000 | 71.38% |
| Logos Global Management LP | 3,156,981 | $233,175,000 | 16.81% |
| Vivo Capital, LLC | 4,220,048 | $311,693,000 | 14.00% |
| Cormorant Asset Management, LP | 1,012,079 | $74,752,000 | 3.04% |
| Redmile Group, LLC | 864,435 | $63,847,000 | 1.11% |
| Nan Fung Group Holdings Ltd | 41,950 | $3,098,000 | 0.99% |
| Artal Group S.A. | 500,000 | $36,930,000 | 0.83% |
| SPHERA FUNDS MANAGEMENT LTD. | 128,706 | $9,506,000 | 0.80% |
| Pier Capital, LLC | 75,362 | $5,566,000 | 0.58% |
| Financial Advisory Group | 31,417 | $2,320,000 | 0.51% |